Thiazolidinedione Derivatives as Anticancer Agents: Synthetic Strategies, SAR, and Therapeutic Potential

Cancer is the second most common cause of mortality after cardiovascular diseases. Over the years, many chemotherapeutic agents have been developed, but the lack of target specificity and selectivity, toxicity to normal cells, and the problem of developing resistance limit their clinical usefulness. This has prompted the search for novel, safer, effective, and highly specific anticancer agents. Thiazolidinedione, a sulfur and nitrogen‐containing five‐membered heterocyclic ring, has shown promising anticancer potential in preclinical studies. Substitutions at different positions on the thiazolidinedione scaffold can overcome the problem of toxicity and drug resistance by targeting cancer with various mechanisms of action. This includes promoting apoptosis of the cancer cells, inhibiting signaling pathways, and cell proliferation in cancers by the activation of peroxisome proliferator‐activated receptor gamma (PPAR‐γ). The thiazolidinedione derivatives also act by inhibiting glyoxalase, TopI/II, GLUT, Bcl2, Ras/Raf, and tyrosine kinase involved in cancer pathogenesis. This review discusses the recent developments in synthetic strategies of thiazolidinedione scaffolds; their mechanism of action, anticancer potential, and structure–activity relationships (SAR) will provide guidance for future directions in cancer research. The recent advancements in the development of thiazolidinedione derivatives as anticancer agents will pave the way for medicinal chemists to direct the synthesis of novel thiazolidinedione derivatives for future clinical use.

• Publication year

  2025

• Venue

  Journal of Heterocyclic Chemistry

• Publication date

  2025-07-29

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1002/jhet.70044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel Thiazolidinedione Linked 1,3,4-Oxadiazole Derivatives as AXL Inhibitors Targeting Breast Cancer: In-Silico Design, ADMET Screening, and MM-GBSA Binding Free Energy

  2024cited by this paper
• Design, synthesis and mechanistic study of N-4-Piperazinyl Butyryl Thiazolidinedione derivatives of ciprofloxacin with Anticancer Activity via Topoisomerase I/II inhibition

  2024cited by this paper
• Thiazolidinedione derivatives in cancer therapy: exploring novel mechanisms, therapeutic potentials, and future horizons in oncology

  2024cited by this paper
• Investigation of the Antifungal and Anticancer Effects of the Novel Synthesized Thiazolidinedione by Ion-Conductance Microscopy

  2023cited by this paper
• New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies

  2023cited by this paper
• Combined In Silico and In Vitro Analyses to Assess the Anticancer Potential of Thiazolidinedione–Thiosemicarbazone Hybrid Molecules

  2023cited by this paper
• SYNTHESIS AND IN SILICO APPROACHES OF NEW SYMMETRIC BIS-THIAZOLIDINE-2,4-DIONES AS Ras AND Raf ONCOPROTEINS INHIBITORS

  2023cited by this paper
• Design, synthesis, in silico docking, ADMET and anticancer evaluations of thiazolidine-2,4-diones bearing heterocyclic rings as dual VEGFR-2/EGFRT790M tyrosine kinase inhibitors

  2022cited by this paper
• Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition

  2022cited by this paper
• Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists

  2022cited by this paper
• Thiazolidinedione-Based Structure Modification of Celastrol Provides Thiazolidinedione-Conjugated Derivatives as Potent Agents against Non-Small-Cell Lung Cancer Cells through a Mitochondria-Mediated Apoptotic Pathway.

  2022cited by this paper
• Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms

  2022cited by this paper
• Synthesis, Anticancer Activity and Molecular Docking Studies of Hybrid Molecules Containing Indole‐Thiazolidinedione‐Triazole Moieties

  2022cited by this paper
• Synthetic strategies and medicinal perspectives of 4‐Thiazolidinones : Recent developments and Structure‐Activity Relationship Studies

  2022cited by this paper
• Pathological Role of HDAC8: Cancer and Beyond

  2022cited by this paper
• Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies

  2022cited by this paper
• Harnessing ROS-Induced Oxidative Stress for Halting Colorectal Cancer via Thiazolidinedione-Based SOD Inhibitors

  2022cited by this paper
• Thiazolidinediones: An In–Depth Study of Their Synthesis and Application to Medicinal Chemistry in the Treatment of Diabetes Mellitus

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• Synthesis, biological evaluation, and molecular docking study of thiophene‐, piperazine‐, and thiazolidinone‐based hybrids as potential antimicrobial agents

  2021cited by this paper
• Design, synthesis, molecular docking and ADME studies of novel indole-thiazolidinedione derivatives and their antineoplastic activity as CDK6 inhibitors

  2021cited by this paper
• Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks.

  2021cited by this paper
• PPAR-γ Modulators as Current and Potential Cancer Treatments

  2021cited by this paper
• Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease.

  2021cited by this paper
• EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance

  2021cited by this paper
• Thiazolidinedione "Magic Bullets" Simultaneously Targeting PPARγ and HDACs: Design, Synthesis, and Investigations of their In Vitro and In Vivo Antitumor Effects.

  2021cited by this paper
• Design, synthesis, and molecular docking studies of thiazolidinediones as PPAR‐γ agonists and thymidylate synthase inhibitors

  2021cited by this paper
• Novel Pan-Pim Kinase Inhibitors With Imidazopyridazine and Thiazolidinedione Structure Exert Potent Antitumor Activities

  2021cited by this paper
• Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors

  2021cited by this paper
• Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential.

  2020cited by this paper
• The role of CDK6 in cancer

  2020cited by this paper
• Synthesis of a novel series of (Z)-3,5-disubstituted thiazolidine-2,4-diones as promising anti-breast cancer agents.

  2020cited by this paper
• Design, synthesis and in vitro antiproliferative activity of new thiazolidinedione-1,3,4-oxadiazole hybrids as thymidylate synthase inhibitors

  2020cited by this paper
• Recent progress on coumarinscaffold‐basedanti‐microbial agents (PartIII)

  2020cited by this paper
• The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy

  2020cited by this paper
• Benzylidene thiazolidinediones: Synthesis, in vitro investigations of antiproliferative mechanisms and in vivo efficacy determination in combination with Imatinib.

  2020cited by this paper
• Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells.

  2020cited by this paper
• Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme.

  2020cited by this paper
• Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation.

  2020cited by this paper
• Indolyl Linked Meta ‐Substituted Benzylidenes as Novel Ligands: Synthesis, Biological Evaluation, and Molecular Docking Studies

  2019cited by this paper
• Cancer statistics, 2019

  2019cited by this paper
• Role of PPAR receptor in different diseases and their ligands: Physiological importance and clinical implications.

  2019cited by this paper
• Thiazolidinones: Synthesis, Reactivity, and Their Biological Applications

  2019cited by this paper
• Design, synthesis of ( Z )‐3‐benzyl‐5‐((1‐phenyl‐3‐(3‐((1‐ substituted phenyl‐1 H ‐1,2,3‐triazol‐4‐yl)methoxy)phenyl)‐1 H ‐pyrazol‐4‐yl)methylene)thiazolidine‐2,4‐dione analogues as potential cytotoxic agents

  2019cited by this paper
• Heterocycles in Medicinal Chemistry

  2019cited by this paper
• Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective

  2019cited by this paper
• In vitro drug metabolism and pharmacokinetics of a novel thiazolidinedione derivative, a potential anticancer compound.

  2019cited by this paper
• Discovery of 5-naphthylidene-2,4-thiazolidinedione derivatives as selective HDAC8 inhibitors and evaluation of their cytotoxic effects in leukemic cell lines.

  2019cited by this paper
• Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators

  2018cited by this paper
• Design, synthesis and molecular modeling studies of novel thiazolidine-2,4-dione derivatives as potential anti-cancer agents

  2018cited by this paper
• Topoisomerases as anticancer targets.

  2018cited by this paper
• Glucose transporters in cancer – from tumor cells to the tumor microenvironment

  2018cited by this paper
• Selective cytotoxic and genotoxic activities of 5-(2-bromo-5-methoxybenzylidene)-thiazolidine-2,4-dione against NCI-H292 human lung carcinoma cells

  2018cited by this paper
• Thiazolidinedione or Rhodanine: A Study on Synthesis and Anticancer Activity Comparison of Novel Thiazole Derivatives.

  2017cited by this paper
• Conventional and microwave-assisted synthesis of new 1H-benzimidazole-thiazolidinedione derivatives: A potential anticancer scaffold.

  2017cited by this paper
• Optimized synthesis and characterization of thiazolidine-2,4-dione for pharmaceutical application

  2017cited by this paper
• Synthesis and in vitro antiproliferative and antibacterial activity of new thiazolidine-2,4-dione derivatives

  2017cited by this paper
• Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities.

  2017cited by this paper
• Biological potential of thiazolidinedione derivatives of synthetic origin

  2017cited by this paper
• Novel 2,4- thiazolidinediones: Synthesis, in vitro cytotoxic activity, and mechanistic investigation.

  2017cited by this paper
• Tobacco carcinogen induces both lung cancer and non‐alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation

  2016cited by this paper
• Contemporary Occupational Carcinogen Exposure and Bladder Cancer: A Systematic Review and Meta-analysis.

  2015cited by this paper
• PIM kinase (and Akt) biology and signaling in tumors.

  2015cited by this paper
• Exposure to environmental chemicals and heavy metals, and risk of pancreatic cancer

  2015cited by this paper
• Thiazolidine-2,4-diones as multi-targeted scaffold in medicinal chemistry: Potential anticancer agents.

  2014cited by this paper
• Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention

  2014cited by this paper
• Antimicrobial activity of thiazolyl benzenesulfonamide-condensed 2,4-thiazolidinediones derivatives

  2013cited by this paper
• Supramolecular structure and spectral studies on mixed-ligand complexes derived from β-diketone with azodye rhodanine derivatives.

  2012cited by this paper
• Novel thiazolidine-2,4-dione mannich bases: Synthesis, characterization and antimicrobial activity

  2012cited by this paper
• The VEGF pathway in cancer and disease: responses, resistance, and the path forward.

  2012cited by this paper
• Synthesis and biological activities of some new thiazolidine derivatives containing pyrazole ring system

  2012cited by this paper
• Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: design and synthesis as anticancer agents.

  2012cited by this paper
• The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases

  2011cited by this paper
• Diversity of genome profiles in malignant lymphoma

  2010cited by this paper
• Synthesis and antimicrobial activity of new tetrahydro‐naphthalene‐thiazolidinedione and thiohydantoine derivatives

  2009cited by this paper
• An efficient method for Knoevenagel condensation: a facile synthesis of 5-arylidenyl 2,4-thiazolidinedione

  2008cited by this paper
• Thiazolidinediones as anti-cancer agents.

  2008cited by this paper
• Microwave induced synthesis of the thiazolidine-2,4-dione motif and the efficient solvent free-solid phase parallel syntheses of 5-benzylidene-thiazolidine-2,4-dione and 5-benzylidene-2-thioxo-thiazolidine-4-one compounds

  2006cited by this paper
• The global health burden of infection‐associated cancers in the year 2002

  2006cited by this paper
• Synthesis and biological activity of natural thiazoles: An important class of heterocyclic compounds

  2005cited by this paper
• Controlled microwave heating in modern organic synthesis.

  2004cited by this paper
• Reduced potential for hepatotoxicity with newer thiazolidinediones?

  2003cited by this paper
• Thymidylate synthase: a critical target for cancer chemotherapy.

  2002cited by this paper
• Substituents effect on the spectral studies on rutheninum(III) complexes of 5(-4'-derivatives phenyldiazo)-3-phenyl-2-thioxo-4-thiazolidinone.

  2002cited by this paper
• Comparative Study of the Structure of Rhodanine, Isorhodanine, Thiazolidine-2,4-dione, and Thiorhodanine

  2002cited by this paper
• The effect of tautomeric rearrangement on the separation of Zn(II) and Cd(II) in ion flotation process with 4-thiazolidinone derivatives

  2002cited by this paper
• Cytogenetic analysis of 363 consecutively ascertained diffuse large B‐cell lymphomas

  1999cited by this paper
• The Current Status of Heterocyclic Combinatorial Libraries.

  1997cited by this paper
• Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

  1985cited by this paper
• Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.

  1984cited by this paper
• Cancer Epidemiology and Prevention

  1976cited by this paper
• Some Analogs of 3-Benzylrhodanine1

  1956cited by this paper
• Stereochemische Untersuchungen der Diketo‐thiazolidine (I.)

  1923cited by this paper
• II.—The chloroacetates of S-alkylthiocarbamides

  year unknowncited by this paper

• No citing papers are available for this paper.